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Abstract
Objective: To determine reference values for incremental shuttle walk distance (ISWD) and peak physiological 
responses during the incremental shuttle walk test (ISWT), as well as to develop a series of predictive equations 
for those variables in healthy adults. Methods: We evaluated 103 healthy participants ≥ 40 years of age (54 
women and 49 men). We fitted each participant with a gas analysis system for use during the ISWT. Oxygen 
consumption (VO2), carbon dioxide production, minute ventilation, heart rate (HR), ISWD, and maximal walking 
velocity (MWV) were obtained as primary outcomes. We also assessed hand grip strength (HGS) and lean body 
mass (LBM). Results: The regression analysis models, including physiological variables, ISWD, and MWV (adjusted 
for age, body mass, height, and sex), produced R2 values ranging from 0.40 to 0.65 (for HR and peak VO2, 
respectively). Using the models including LBM or HGS, we obtained no significant increase in the R2 values 
for predicting peak VO2, although the use of those models did result in slight increases in the R
2 values for 
ISWD and MWV (of 8% and 12%, respectively). The variables ISWD, MWV, and ISWD × body mass, respectively, 
explained 76.7%, 73.3%, and 81.2% of peak VO2 variability. Conclusions: Our results provide reference values 
for ISWD and physiological responses to the ISWT, which can be properly estimated by determining simple 
demographic and anthropometric characteristics in healthy adults ≥ 40 years of age. The ISWT could be used 
in assessing physical fitness in the general adult population and in designing individualized walking programs.
Keywords: Reference values; Pulmonary gas exchange; Walking; Exercise test.
Resumo
Objetivo: Determinar valores de referência para a distância caminhada (DC) e para respostas fisiológicas durante 
o teste de caminhada com carga progressiva (TCCP) e desenvolver equações preditivas para essas variáveis em 
adultos saudáveis. Métodos: Foram avaliados 103 participantes saudáveis com idade ≥ 40 anos (54 mulheres 
e 49 homens). Os participantes usaram um sistema de análise de gases durante o TCCP. Consumo de oxigênio 
(VO2), liberação de gás carbônico, ventilação minuto, frequência cardíaca (FC), DC e velocidade máxima da 
caminhada (VMC) foram obtidos como desfechos primários. Avaliamos também a força de preensão manual (FPM) 
e a massa magra corporal (MMC). Resultados: Os modelos de regressão utilizando variáveis fisiológicas, DC e 
VMC ajustados por idade, massa corporal, estatura e sexo apresentaram valores de R2 entre 0,40 e 0,65 (para 
FC e pico de VO2, respectivamente). Os modelos incluindo MMC e FPM não aumentaram consideravelmente os 
valores de R2 na previsão do pico de VO2, embora esses modelos tenham aumentado discretamente os valores do 
R2 para DC e VMC (8% e 12%, respectivamente). As variáveis DC, VMC e DC × massa corporal, respectivamente, 
explicaram 76,7%, 73,3% e 81,2% da variabilidade do pico de VO2. Conclusões: Nossos resultados originaram 
valores de referência para a DC e respostas fisiológicas ao TCCP, que podem ser estimados adequadamente por 
características demográficas e antropométricas simples em adultos saudáveis com idade ≥ 40 anos. O TCCP 
poderia ser utilizado na avaliação da capacidade física na população geral de adultos e no desenvolvimento de 
programas de caminhada individualizados.
Descritores: Valores de referência; Troca gasosa pulmonar; Caminhada; Teste de esforço.
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Introduction
The incremental shuttle walk test (ISWT) 
was developed in order to assess the functional 
exercise capacity of patients with COPD.(1) The 
test subject walks back and forth along a 10-m 
flat course, with progressive increases in pace 
imposed by audio signals, until no longer able 
to maintain the pace. The incremental character 
of the ISWT yields physiological responses closer 
to those observed in cardiopulmonary exercise 
testing (CPET).(2) Some authors argue that, as 
an externally paced walk test, the ISWT is more 
reproducible and yields greater physiological 
responses in comparison with self-paced walk 
tests.(3) One of the greatest advantages of the 
ISWT is its simplicity. The incremental shuttle 
walk distance (ISWD) is generally used as an 
index of cardiorespiratory fitness and has been 
suggested as a prognostic indicator in patients 
with chronic disease.(4)
Because of its simplicity and low cost, walking 
is the most popular exercise for middle-aged and 
older adults. In healthy subjects, the heart rate 
variability threshold was reported to be a valid 
tool for estimating the ventilatory threshold 
during the ISWT.(5) The ISWT has also proven 
useful for quantifying the benefits of a walking 
program designed for healthy individuals.(6) Studies 
evaluating the ISWT in healthy subjects have 
shown that the ISWT is valid and responsive. 
Despite the widespread use of the ISWT in clinical 
settings, few studies have assessed reference 
values and physiological responses to the test. 
Recently, the ISWD has been investigated in 
healthy subjects, and regression equations have 
been developed, allowing a better interpretation 
of walking performance.(7-9) Two such studies 
enrolled participants with comorbidities,(7,9) 
whereas another included only healthy individuals.
(8) However, to our knowledge, there have been 
no studies evaluating physiological responses 
to the ISWT in healthy subjects in other than a 
superficial manner.
Although the operational simplicity of walk 
tests is recognized as their most important quality, 
the ISWT has been evaluated with the aid of 
sophisticated telemetric gas analysis systems 
in order to evaluate physiological responses, 
especially in patients with cardiorespiratory 
diseases.(2,10) In such patients, the peak oxygen 
consumption (VO2) achieved on the ISWT 
exhibits a strong correlation with that achieved 
in CPET performed on a treadmill or on a cycle 
ergometer. (10,11) Therefore, the ISWT appears to 
induce a maximum exercise response that is 
appropriate for assessing functional capacity.(12) 
Elucidation of such physiological responses might 
be useful for assessing exercise capacity and for 
designing walking programs for middle-aged 
and older adults. In addition, reference values, 
especially for VO2 and ISWD, might provide an 
easy way to assess the functional exercise capacity 
in patients with chronic diseases. 
In this study, our primary objective was to 
determine reference values for ISWD and peak 
physiological responses during the ISWT, developing 
a series of simple predictive equations for those 
variables in healthy middle-aged adults and in 
healthy older adults. We also assessed the influence 
that body composition and muscle strength have 
on the main physiological variables obtained 
during the ISWT.
Methods
We conducted a cross-sectional study to 
evaluate the physiological responses to the ISWT 
in 103 healthy adults aged 40 years and older. 
The Research Ethics Committee of the Federal 
University of São Paulo, located in the city of 
São Paulo, Brazil, approved the study, and all 
participants provided written informed consent.
We recruited a convenience sample from among 
employees of the institution and residents of the 
surrounding community. The following individuals 
were ineligible for inclusion in the study: those 
with a body mass index > 35 kg/m2; those who 
used a walking aid; those who exhibited abnormal 
post-bronchodilator spirometric results(13); those 
who reported having cardiorespiratory, metabolic, 
neuromuscular, or musculoskeletal disease; and 
those who were current smokers. 
Eligible participants underwent a series of 
evaluations over the course of two mornings, 
with a 7-day interval between the two. On day 
1, the participants completed a physical activity 
readiness questionnaire, a face-to-face interview 
based on the main cardiovascular risk factors, and 
a physical activity questionnaire in accordance 
with the American College of Sports Medicine 
recommendations(14) so that we could exclude 
those involved in high-intensity exercise and 
sports. They also underwent spirometry, hand grip 
strength (HGS) assessment, and anthropometric 
and body composition measurements. Those 
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who met the eligibility criteria returned on day 
2 and underwent three ISWTs, 20 min apart.
Body mass (in kg) and height (in m) were 
measured, and the body mass index (in kg/m2) was 
calculated. Body composition was assessed using 
a portable scale with a tetrapolar bioelectrical 
impedance system (TBF-310GS; Tanita, Arlington 
Heights, IL, USA).(15) Total body fat (TBF), total 
body water, and lean body mass (LBM) were 
assessed using regression equations.(16) The LBM 
was also expressed as a percentage of the predicted 
value.(17) Spirometry was performed using a hand-
held spirometer (Spiropalm; Cosmed, Pavona 
di Albano, Italy) in accordance with the criteria 
established by the Brazilian Thoracic Association.
(13) We measured FEV1, FVC, and FEV1/FVC ratio. 
The HGS of the dominant side was assessed 
using a hydraulic dynamometer (HS5001; Carci, 
São Paulo, Brazil).(18) Three measurements were 
performed at least 30 s apart. The highest value 
was selected for further analysis.
We conducted the ISWTs in a 10-m corridor, 
increasing the pace by 0.17 m/s every minute.(1) 
Dyspnea and leg fatigue were quantified before 
and after each test with the Borg scale. Three 
ISWTs were performed 20 min apart. The ISWD 
(in m) and maximum walking velocity (MWV, in 
m/s) obtained on the third test were selected for 
further analysis. Because the ISWT was developed to 
assess the functional exercise capacity of patients 
with lung disease, the original protocol consisted 
of 12 levels (total distance, 1,020 m).(1) However, 
because we applied the test to healthy subjects, 
we extended it to 15 levels (1,500 m) in order 
to minimize the ceiling effect.
During the third ISWT, expired gases were 
collected and assessed by a portable telemetric 
gas analysis system (K4b2; Cosmed; Pavona di 
Albano, Italy). The physiological responses were 
analyzed breath-by-breath, and the data were 
filtered every 15 s. The following variables were 
focused at the peak of the ISWT: VO2, carbon 
dioxide production, HR, and minute ventilation.
The data were evaluated descriptively and 
are presented as mean ± standard deviation. 
Sex-related differences in the main physiological 
variables and the rate of perceived exertion were 
evaluated using Student’s t-test or the Mann-
Whitney test. Pearson’s or Spearman’s coefficients 
were used in order to assess bivariate correlations. 
To ensure that the ISWD obtained in the third 
test, carried out using the gas analysis system, 
was not inferior to that obtained in the second 
test, conducted without the equipment, we 
evaluated the intraclass correlation coefficient 
(ICC) with its 95% CI between those measures 
and compared their mean values using paired 
Student’s t-test.
We calculated the sample size considering a 
minimum acceptable coefficient of correlation 
of 0.70 or a coefficient of determination (R2) 
of 0.49. Assuming an alpha error of 0.05 and a 
beta error of 0.20, a minimum of 12 observations 
for each variable included in the model would 
be sufficient. Therefore, 80 participants were 
necessary, and we were able to include up to 
8 variables in each model. A series of multiple 
linear regression equations was developed using 
the main physiological responses as dependent 
variables. The models were first adjusted for 
age, body mass, height, and sex. This procedure 
was applied because these variables are easily 
obtained. For VO2, MWV, and ISWD (the most 
important variables related to aerobic exercise 
capacity), the models were also adjusted for body 
composition variables and HGS. Regarding body 
composition, we chose LBM and TBF, which 
presented the strongest correlations in the previous 
bivariate analysis. In addition, we used linear 
regressions in alternative prediction models to 
determine whether peak VO2 correlated with 
ISWD, with ISWD × body mass, and with MWV. 
Multicollinearity was assessed before starting 
the regression procedures. The probability of 
an alpha error was set at 0.05 for all analyses. 
We performed the statistical analysis with the 
Statistical Package for the Social Sciences, version 
15.0 (SPSS Inc., Chicago, IL, USA) and SigmaStat, 
version 3.1 (Systat Software Inc., San Jose, CA, 
USA).
Results
The sample comprised 103 participants (54 
women and 49 men), and the mean age was 
60 ± 10 years (Table 1). The participants were 
distributed within the following age brackets: 
40-49 years (13 women and 12 men); 50-59 years 
(12 women and 11 men); 60-69 years (14 women 
and 14 men); and ≥ 70 years (15 women and 
12 men). There were no significant differences 
among the four age groups studied in terms of 
the proportions of women and men. Between the 
second and third ISWT, the ISWD reliability was 
excellent (ICC = 0.973; 95% CI: 0.960-0.982) 
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and there was no significant difference between 
the mean values (510 ± 148 m vs. 519 ± 161 m).
The regression analysis models, using 
physiological variables, ISWD, and MWV as 
dependent variables and adjusted for age, 
body mass, height, and sex, showed R2 values 
ranging from 0.40 to 0.65 (for HR and peak 
VO2, respectively; Table 2). Applying the model 
including LBM and that including HGS did not 
result in a significant increase in the R2 values 
for predicting peak VO2 (Table 2), although the 
use of those models did result in slight increases 
in the R2 values for ISWD and MWV (of 8% and 
12%, respectively). We selected ISWD, MWV, 
and ISWD × body mass as the sole determinants 
of peak VO2. In three different models, those 
variables determined 76.7%, 73.3%, and 81.2% 
of the peak VO2, respectively (Figure 1).
Discussion
This study investigated the major physiological 
responses to ISWT in healthy subjects. We derived 
a series of equations that can predict ISWD, as 
well as cardiovascular, ventilatory, and metabolic 
responses during the ISWT. Age and sex had 
significant influences on those variables. However, 
after adjusting for sex and age, we found that 
MWV and ISWD were the main determinants of 
peak VO2, regardless of body composition and 
peripheral muscle strength.
The main finding of this study was the 
considerable influence that MWV and ISWD had 
on the peak VO2 obtained on the ISWT. The 
correlations between peak VO2 and ISWD, between 
peak VO2 and MWV, and between peak VO2 and 
Table 1 - General characteristics of the study sample.
Variable
Sex
Female Male
(n = 54) (n = 49)
Mean SD Mean SD
Age, year 59 11 59 9
BM, kg* 68 14 80 12
Height, m* 1.57 0.07 1.71 0.07
BMI, kg/m2 27 5 27 3
TBF, kg* 31 10 20 7
TBF, % of total BM* 35 6 25 5
LBM, kg* 39 5 58 7
LBM, % of total BM* 64 6 74 5
LBM, % of predicted 102 7 103 5
LBMI, kg/m2* 17 1 20 1
HGS, kgf* 26 5 43 8
BM: body mass; BMI: body mass index; TBF: total body 
fat; LBM: lean body mass; LBMI: lean body mass index; 
and HGS: handgrip strength. *p < 0.05 (females vs. males).
Table 2 - Linear prediction equations, adjusted for age, body mass, height, sex, body composition, and 
muscle function, for peak physiological responses, total distance walked, and maximum walking velocity 
related to the incremental shuttle-walk test.
Variable Modela
Constant
Age, 
years
Body 
mass, 
kg
Height, 
m
Sexc
HGS, 
kgf
LBM, 
kg
TBF, 
%
R2 Sy.x
Mean LLNb
VE, L/min A −43.7 −67.2 −0.5* 0.1 69.2* 13.0* - - - 0.54 14.3
HR, bpm A 146.2 117.9 −1.1* −0.4* 55.5* −2.1 - - - 0.40 17.2
VCO2, mL/min A 137.6 −493.2 −22.5* 5.4* 1,317.9* 554.5* - - - 0.63 383.5
Peak VO2, mL/
min
A 268.6 −337.9 −21.1* 9.2* 1,101.1* 535.6* - - - 0.65 368.1
B −134.1 −750.6 −16.2* 8.8 938.7* 297.5 14.8* - - 0.65 374.9
C −1,206.3 −1,731.7 −12.6* −21.0 883.3 207.8 - 56.0* 27.8 0.65 319.2
ISWD, m A 347.7 186.8 −7.2* −3.0* 472.3* 137.2* - - - 0.65 97.8
B 223.7 86.1 −5.8* −3.2* 421.3 67.1 4.8* - - 0.73 83.6
C −54.6 −198.4 −5.8* −4.3 666.0* 75.3 - 2.1 0.64 0.68 87.4
MWV, m/s A 1.59 1.32 −0.01* −0.004* 0.70* 0.22* - - - 0.60 0.17
B 0.89 0.66 −0.008* −0.005* 0.92* 0.06 0.008* - - 0.72 0.14
C 0.55 0.32 −0.009* −0.007 1.23* 0.11 - 0.003 0.002 0.67 0.14
LLN: lower limit of normal (calculated as 1.646 × Sy.x); HGS: handgrip strength; LBM: lean body mass; TBF: total body 
fat; Sy.x: standard error about linear regression; VE: minute ventilation; VCO2: carbon dioxide production; VO2: oxygen 
uptake; ISWD: incremental shuttle walk distance; and MWV: maximum walking velocity. aModel A included age, body 
mass, height and sex; model B included age, body mass, height, sex, and HGS; and model C included age, body mass, 
height, sex, LBM, and TBF. bUse “mean” column for prediction of the expected values and “LLN” column for lower 
limit of normal. cSex: males = 1; females = 0. *Significant predictors (p < 0.05).
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Figure 1 - Significant correlations between peak VO2 and incremental shuttle walk distance (ISWD), as 
well as between peak VO2 and maximal walking velocity (MWV), during the incremental shuttle walk test.
ISWD × body mass ranged from 0.75 to 0.90. 
These values are similar to those described in the 
literature for the correlation between ISWD and 
peak VO2 obtained under laboratory conditions in 
patients with cardiopulmonary disease. Consistent 
correlations between peak VO2 and ISWD or 
between peak VO2 and ISWD × body mass obtained 
in CPET have been described in COPD patients 
(range, 0.73-0.88).(2,10,19,20) Correlations of this 
magnitude have also been described during CPET 
in patients with idiopathic pulmonary fibrosis(21) 
and in patients with heart disease.(22-24) These 
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results support the assertion that the ISWT is a 
suitable tool to assess the functional capacity 
of such patients. Our results indicate that the 
peak VO2 obtained during the ISWT might be 
adequately estimated by using ISWD, MWV, or 
body mass. In fact, Léger & Lambert(25) reported 
similar results in the study in which they developed 
the precursor to the ISWT (the incremental shuttle 
run test). In that study, the peak VO2 of young 
adults was adequately predicted by the running 
speed, with a correlation of r = 0.84. In a study 
conducted by Cooper, who used the 12-min run 
test,(26) the 12-min run distance was also the 
most important determinant of cardiorespiratory 
fitness in healthy young adults, a finding similar 
to those of the present study. Even in CPET, the 
work rate, or power, has been identified as the 
main determinant of peak VO2.
(27) Because the 
ISWT is performed on a flat surface, the MWV 
ultimately represents the workload of the test.
Sex and age influenced the main variables 
obtained on the ISWT (peak VO2, ISWD, and 
MWV). Several studies have reported that peak 
VO2 suffers a decline with advancing age and 
is lower in women,(28,29) even when allometric 
correction is used.(30) In the present study, R2 
values for ISWD, adjusted for age, body mass, 
height, and sex, ranged from 15% to 22%, 
which are higher than those reported in the 
study conducted by Jürgensen et al.,(7) in which 
those attributes explained 50% of the ISWD 
variability. This difference might be attributable 
to the characteristics of the sample evaluated 
in that study, which included individuals with 
mild hypertension and smokers, whereas only 
healthy participants were included in the present 
study. We found that body composition and 
HGS, although presenting consistent correlations 
with peak VO2, did not sufficiently increase the 
predictive power of the equations adjusted only 
for demographic and anthropometric attributes. 
Neder et al.(29) reported similar results in a study 
involving CPET on a cycle ergometer. In that 
study, the residuals of the equations involving 
muscle strength and body composition were 
narrowed, although the R2 was not sufficiently 
increased.(29) Our results suggest that equations 
including age, sex, body mass, and height are 
useful because those variables are very simple to 
obtain and provide R2 values similar to those of 
models with variables that are more difficult to 
obtain, such as body composition and muscle 
function (Table 2).
Various cardiovascular and ventilatory 
variables were determined in the present study 
by a combination of age, sex, height, and body 
mass (R2 ranging from 0.54 to 0.65). Our results 
are similar to those described by Neder et al.,(29) 
who reported that several cardiovascular and 
ventilatory variables might be determined by 
the combination of age, sex, height, and body 
mass, with an R2 ranging from 0.102 to 0.691.
The use of a gas analysis system did not result 
in worse performance during the third ISWT in 
the present study, given that the results of the 
second and third ISWTs were not significantly 
different and exhibited excellent reliability. Our 
results differ from those described by Singh et al.,(10) 
who reported a shorter ISWD with the use of a 
telemetric gas analysis system. This discrepancy 
might be explained primarily by the total weight of 
the equipment we used, which was lower than the 
4.1 kg of that used by Singh et al.(10) In addition, 
those authors(10) evaluated COPD patients, whereas 
our study involved only healthy participants. Our 
results show that, despite some minor discomfort 
related to the use of a face mask, the use of the 
equipment had no impact on the ISWD.
Our study has limitations that should be 
considered. The main limitation was that we 
did not perform CPET. However, comparing our 
results with those expected for CPET on a cycle 
ergometer derived from a randomized study,(29) 
the measured peak VO2 during the ISWT was 
significantly higher than the expected values 
for CPET on a cycle ergometer (1,760 ± 608 
mL/min vs. 1,568 ± 438 mL/min, p = 0.017). 
Regarding CPET on a treadmill, when we compare 
our results with those found in another study 
conducted in Brazil,(28) albeit qualitatively, the 
peak VO2 achieved during the ISWT corresponded 
to 80.6-108.2% of the peak VO2 expected in that 
study. Another limitation was the convenience 
sampling technique that we used, which might 
have resulted in overestimation of the normal 
physiological responses. However, we took care 
to include only healthy individuals who were not 
involved in sports or vigorous physical activity. 
We believe that this minimized the bias of the 
sampling technique used.
Our results provide reference values for ISWD 
and physiological responses to the ISWT, which 
can be properly estimated by determining simple 
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demographic and anthropometric characteristics 
in healthy adults ≥ 40 years of age. The inclusion 
of body composition and muscle function data 
improved the power of those estimations only slightly. 
Therefore, the ISWT could be used in assessing 
physical fitness in the general adult population 
and in designing individualized walking programs. 
Because the pace set in the initial levels of the 
ISWT is too slow for healthy individuals, future 
studies should investigate ways in which the original 
protocol can be adapted for use in this population. 
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